S. Andrew

University of Birmingham — United Kingdom

Medicine · Health Sciences

43h-index8.3kcitations138works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Glioma Diagnosis and Treatment(89), Cancer, Hypoxia, and Metabolism(22), Cancer Genomics and Diagnostics(18), Radiomics and Machine Learning in Medical Imaging(13), Brain Metastases and Treatment(12)

Publications138 total

The diagnostic value of combined TCD and CTA in intracranial arterial stenosis
Cambridge Science Advance·2025
Do State and Trait General and Social Anxiety Affect Theory of Mind?
2025Open Access
The Massive and Quiescent Elliptical Host Galaxy of the Repeating Fast Radio Burst FRB20240209A
arXiv (Cornell University)·2024Open Access
The Role of Endoscopy for Primary and Secondary Prophylaxis of Variceal Bleeding
Gastrointestinal Endoscopy Clinics of North America·2023· 3 cited
Longitudinal analysis of serum-derived extracellular vesicle RNA to monitor dacomitinib treatment response in EGFR-amplified recurrent glioblastoma patients
Neuro-Oncology Advances·2023· 4 citedOpen Access
Impact of <i>STK11</i> mutation on first-line immune checkpoint inhibitor (ICI) outcomes in a real-world KRAS G12C mutant lung adenocarcinoma cohort.
Journal of Clinical Oncology·2021· 11 cited
KRYSTAL-2: A phase I/II trial of adagrasib (MRTX849) in combination with TNO155 in patients with advanced solid tumors with KRAS G12C mutation.
Journal of Clinical Oncology·2021· 53 cited
Corrigendum to: Recycling drug screen repurposes hydroxyurea as a sensitizer of glioblastomas to temozolomide targeting de novo DNA synthesis, irrespective of molecular subtype
Neuro-Oncology·2020Open Access
A Hyperactive RelA/p65-Hexokinase 2 Signaling Axis Drives Primary Central Nervous System Lymphoma
Cancer Research·2020· 36 citedOpen Access
Musculoskeletal Outside Interpretation (MOI-RADS): an automated quality assurance tool to prospectively track discrepancies in second-opinion interpretations in musculoskeletal imaging
Skeletal Radiology·2020· 3 cited
Dissecting the immunosuppressive tumor microenvironments in Glioblastoma-on-a-Chip for optimized PD-1 immunotherapy
eLife·2020· 149 citedOpen Access
Author response: Dissecting the immunosuppressive tumor microenvironments in Glioblastoma-on-a-Chip for optimized PD-1 immunotherapy
2020· 3 citedOpen Access
Neuro-Oncology Practice Clinical Debate: Early treatment or observation for patients with newly diagnosed oligodendroglioma and small-volume residual disease
Neuro-Oncology Practice·2020· 2 citedOpen Access
Exploring Predictors of Response to Dacomitinib in <i>EGFR</i>-Amplified Recurrent Glioblastoma
JCO Precision Oncology·2020· 29 citedOpen Access
Abstract A65: Longitudinal detection of TERT-mutant plasma cell-free circulating tumor DNA in newly diagnosed glioblastoma patients
Clinical Cancer Research·2020· 1 cited
Single-agent ONC201 in recurrent H3 K27M-mutant diffuse midline glioma.
Journal of Clinical Oncology·2020· 2 cited
Clinical experience of ONC201 in patients with recurrent H3 K27M-mutant spinal cord glioma.
Journal of Clinical Oncology·2020· 8 cited
“Real world” use of a highly reliable imaging sign: “T2-FLAIR mismatch” for identification of IDH mutant astrocytomas
Neuro-Oncology·2020· 128 citedOpen Access
Functional and topographic effects on DNA methylation in IDH1/2 mutant cancers
Scientific Reports·2019· 58 citedOpen Access
ATIM-37. PHASE II, OPEN-LABEL, SINGLE ARM, MULTICENTER STUDY OF AVELUMAB WITH HYPOFRACTIONATED RADIATION (HFRT) FOR ADULT PATIENTS WITH SECONDARILY TRANSFORMED IDH-MUTANT GLIOBLASTOMA (GBM)
Neuro-Oncology·2019· 3 citedOpen Access
page 1 of 7Next →

Frequent Co-authors

Tracy T. Batchelor(24), Daniel P. Cahill(16), A. John Iafrate(16), Hiroaki Wakimoto(12), William T. Curry(10), Patrick Y. Wen(9), David N. Louis(8), Kensuke Tateishi(7), Matija Snuderl(7), Elizabeth R. Gerstner(7), B Bernstein(6), Jörg Dietrich(6), Nina Lelic(5), Rajan Jain(5), Bruce R. Rosen(5), Joshua E. Allen(5), Dora Dias‐Santagata(5), Darrell R. Borger(5), Samuel D. Rabkin(4), Brian V. Nahed(4)